FDA NDC Directory · JSON-LD · Markdown

Arazlo

NDC 0187-2098 · HUMAN PRESCRIPTION DRUG · LOTION

Generic nametazarotene
Labeler / ManufacturerBausch Health US, LLC
Marketing categoryNew Drug Application (innovator) · App NDA211882
Dosage form / routeLOTION · TOPICAL
Active ingredientsTAZAROTENE (.45 mg/g)
Marketing started20191219
Package count2

External sources

Source: openFDA. Public-domain (CC0).